natriuretic-peptide--c-type has been researched along with Hyperandrogenism* in 2 studies
2 other study(ies) available for natriuretic-peptide--c-type and Hyperandrogenism
Article | Year |
---|---|
Role of C-type natriuretic peptide in polycystic ovary syndrome.
To evaluate serum C-type natriuretic peptide (CNP) and androgen concentrations in women with polycystic ovary syndrome (PCOS), and compare them with the healthy group.. The present study was carried out prospectively at the Near East University Hospital, between July 15, 2019 and September 1, 2020. Out of the 90 patients aged between 18 and 40 years old who were enrolled, the final study population consisted of 36 patients with PCOS and 30 healthy women.. Body mass index, free androgen index, serum androstenedione, total testosterone, free testosterone, and CNP were significantly higher and serum sex-hormone-binding globulin level was lower in the PCOS group.. We revealed that serum CNP levels are high in PCOS patients. The mechanism of the relationship between this increase and hyperandrogenism or anovulation is not known, but these findings provide a direction for new studies.. GOV: NCT04006171. Topics: Adolescent; Adult; Androgens; Female; Humans; Hyperandrogenism; Natriuretic Peptide, C-Type; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2023 |
High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice.
Topics: Adult; Androgen Receptor Antagonists; Animals; Anovulation; Case-Control Studies; Chorionic Gonadotropin; Disease Models, Animal; Estrogen Receptor Antagonists; Female; HEK293 Cells; Humans; Hyperandrogenism; Mice, Inbred BALB C; Natriuretic Peptide, C-Type; Ovary; Polycystic Ovary Syndrome; Receptors, Androgen; Receptors, Atrial Natriuretic Factor; Receptors, Estrogen; Young Adult | 2018 |